Analyst Ratings For NYSE:DGX – Quest Diagnostics (NYSE:DGX)
Today, NYSE:DGX – Quest Diagnostics (NYSE:DGX) stock received an upgrade by William Blair from Market Perform ➝ Outperform.
Some recent analyst ratings include
- 6/8/2018-William Blair Upgrade from a “Market Perform ➝ Outperform” rating to a “” rating.
- 5/29/2018-Morgan Stanley Upgrade from a “Equal Weight ➝ Overweight” rating to a “” rating.
- 5/28/2018-Barclays Reiterated Rating of Hold.
- 5/25/2018-Mizuho Reiterated Rating of Buy.
- 5/1/2018-Robert W. Baird Upgrade from a “Neutral ➝ Outperform” rating to a “” rating.
Dividend information for NYSE:DGX – Quest Diagnostics (NYSE:DGX)
NYSE:DGX – Quest Diagnostics (NYSE:DGX) pays an annual dividend of $2.00 with a yield of 1.82% and an average dividend growth of 11.70% based on a 3 Year Average..
Dividend History for NYSE:DGX – Quest Diagnostics (NYSE:DGX)
- On 5/14/2018 NYSE:DGX – Quest Diagnostics announced a quarterly dividend of $0.50 1.94% with an ex dividend date of 7/6/2018 which will be payable on 7/23/2018.
- On 2/1/2018 NYSE:DGX – Quest Diagnostics announced a quarterly dividend of $0.50 1.99% with an ex dividend date of 4/3/2018 which will be payable on 4/18/2018.
- On 11/29/2017 NYSE:DGX – Quest Diagnostics announced a quarterly dividend of $0.45 1.83% with an ex dividend date of 1/8/2018 which will be payable on 1/24/2018.
- On 8/18/2017 NYSE:DGX – Quest Diagnostics announced a quarterly dividend of $0.45 1.72% with an ex dividend date of 10/2/2017 which will be payable on 10/18/2017.
- On 5/16/2017 NYSE:DGX – Quest Diagnostics announced a quarterly dividend of $0.45 1.71% with an ex dividend date of 7/6/2017 which will be payable on 7/24/2017.
- On 2/21/2017 NYSE:DGX – Quest Diagnostics announced a quarterly dividend of $0.45 1.88% with an ex dividend date of 4/3/2017 which will be payable on 4/19/2017.
- On 11/11/2016 NYSE:DGX – Quest Diagnostics announced a quarterly dividend of $0.45 with an ex dividend date of 1/6/2017 which will be payable on 1/25/2017.
Recent Insider Trading Activity For NYSE:DGX – Quest Diagnostics (NYSE:DGX)
NYSE:DGX – Quest Diagnostics (NYSE:DGX) has insider ownership of 1.79% and institutional ownership of 88.31%.
- On 5/29/2018 Jeffrey M Leiden, Director, sold 1,644 with an average share price of $105.61 per share and the total transaction amounting to $173,622.84.
- On 5/25/2018 Mark Guinan, Insider, sold 61,533 with an average share price of $105.71 per share and the total transaction amounting to $6,504,653.43.
- On 5/25/2018 Stephen H Rusckowski, Chairman, sold 168,490 with an average share price of $107.00 per share and the total transaction amounting to $18,028,430.00.
- On 3/8/2018 Jon R Cohen, SVP, sold 83,669 with an average share price of $104.20 per share and the total transaction amounting to $8,718,309.80.
- On 3/5/2018 Catherine T Doherty, SVP, sold 5,556 with an average share price of $101.00 per share and the total transaction amounting to $561,156.00.
- On 3/5/2018 J. E Davis, EVP, sold 5,122 with an average share price of $101.00 per share and the total transaction amounting to $517,322.00.
- On 2/28/2018 Catherine T Doherty, SVP, sold 1,820 with an average share price of $104.38 per share and the total transaction amounting to $189,971.60.
Recent Trading Activity for NYSE:DGX – Quest Diagnostics (NYSE:DGX)
Shares of NYSE:DGX – Quest Diagnostics closed the previous trading session at 109.91 up +2.31 2.15% with shares trading hands.